SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-22-010113
Filing Date
2022-04-25
Accepted
2022-04-25 16:01:35
Documents
4
Period of Report
2022-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a-2022.htm DEF 14A 566139
2 GRAPHIC avalo-logoxblk.jpg GRAPHIC 48586
3 GRAPHIC avalotherapeuticsinc_vsmvx.jpg GRAPHIC 525664
4 GRAPHIC avalotherapeuticsinc_vsmvxa.jpg GRAPHIC 192246
  Complete submission text file 0001628280-22-010113.txt   1622276
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37590 | Film No.: 22849662
SIC: 2834 Pharmaceutical Preparations